Mualliflar

  • Ikhtiyarova G.A., Tolibova A.E.

##semicolon##

hemolytic disease, Rh immunization, intrauterine transfusion, IgG, Dopplerometry.

##submission.citations##

Basu S., Kaur R., Kaur G., Jain S. Severe hemolytic disease of newborn due to non-Rh D antibody. Indian J. Pediatr. 2011; 78(3): 366-7.

Clausen F.B. Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care. Prenat. Diagn. 2014; 34(5): 409-15.

Daniels G., Finning K., Martin P., Massey E. Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat. Diagn. 2009; 29(2): 101-7.

Dodd J.M. et al. Ultrasound markers of fetal anemia. Ultrasound Obstet Gynecol. 2018; 52(3): 243–250.

Duplantie J., Martinez Gonzales O., Bois A., Nshimyumukiza L., Gekas J., Bujold E. et al. Cost-effectiveness of the management of rh-negative pregnant women. J. Obstet. Gynaecol. Can. 2013; 35(8): 730–40.

Friszer S. et al. Intrauterine transfusions in RhD alloimmunization. Fetal Diagn Ther. 2019; 45(4): 271–278.

Ikhtiyarova, G. A., Dustova, N. K., Kudratova, R. R., Bakhramova, S. U., & Khafizova, D. B. Pre-course training of women with reproductive loss of fetus in anamnesis. Annals of the Romanian Society for Cell Biology. 2021; 25(1): 6219–6226.

Kerimova E.A. et al. Immunoglobulin subclasses in perinatal medicine. J. Clin Immunol. 2021; 41(4): 870–877.

Kim W.D., Lee Y.H. A fatal case of severe hemolytic diseases of the newborn associated with anti-Jk(b). J. Korean Med. Sci. 2008; 21(1): 151–4.

Konoplyanikov A.G., Pavlova N.G. Izoserologicheskaya nesovmestimost' krovi materi i ploda. In: Akušerstvo. Nacional'noe rukovodstvo. 2015: 324–334.

Liumbruno G.M., D’alessandro A., Rea F., Piccinini V., Catalano L., Calizzani G. et al. The role of antenatal immunoprophylaxis in the prevention of maternal foetal anti Rh (D) alloimmunisation. Blood Transfus. 2010; 8(1): 8–16.

Manzanares S., Entrala C., Sánchez-Gila M., Fernández-Rosado F., Cobo D., Martinez E. et al. Noninvasive fetal RhD status determination in early pregnancy. Fetal Diagn. Ther. 2014; 35(1): 7–12.

Moise K. Jr. Management of rhesus alloimmunization in pregnancy. Obstet. Gynecol. 2008; 112(1): 164–76.

Moise K.J. Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Semin. Fetal Neonatal Med. 2008; 13(4): 207–14.

Musz1c vgynski J.A. et al. Transfusion and immune response. Transfusion. 2017; 57(5): 1125–1133.

Navruzova, N. O., Karshiyeva, E. E., Ikhtiyarova, G. A., Hikmatova, N. I., Olimova, N. I., & Muminova, N. K. Clinical and laboratory markers forecasting of cervical diseases and its prevention. Annals of the Romanian Society for Cell Biology. 2021; 25(4): 13098–13110.

NICE Clinical Guidelines. Routine antenatal anti-D prophylaxis. UK: NICE; 2022.

Oripova, F. S., Ikhtiyarova, G. A., Shukurlaev, K., & Khamdamova, M. T. New methods of correction of inflammatory diseases of the genitalia (clinical and experimental study). Annals of the Romanian Society for Cell Biology. 2021; 25(4): 1865–1872.

Poole J., Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus. Med. Rev. 2007; 21(1): 58–71.

Potdar O. et al. Management of Rh isoimmunization. Indian J. Obstet Gynecol. 2020; 70(1): 21–27.

Rezus-izoimmunizatsiya. Gemoliticheskaya bolezn' ploda. Klinicheskie rekomendatsii. ROAG. Moskva, 2020.

Roberts I.A. The changing face of haemolytic disease of the newborn. Early Hum. Dev. 2008; 84(8): 515–23.

Sapa A., Jonkisz A., Zimmer M., Kłósek A., Woźniak M. Diagnostic utility of RHD-gene detection in maternal plasma in the prophylaxis of feto-maternal Rh-incompatibility. Ginekol. Pol. 2014; 85(8): 570–6.

Sabita B., Ravneet K. Hemolytic disease of the fetus and newborn: current trends and perspectives. Asian J. Transfus. Sci. 2011; 5(1): 3–7.

Savelyeva G.M., Kurcer M.A., Panina O.B., Sichinava L.G., Konoplyanikov A.G. Gemoliticheskaya bolezn' ploda u beremennykh s rezus-sensibilizatsiey. Metodicheskoe pismo Minzdravsotsrazvitiya RF, 2012. – 18 s.

Thakral B., Agrawal S.K., Dhawan H.K., Saluja K., Dutta S., Marwaha N. First report from India of haemolytic disease of the newborn by anti c and anti E in Rh (D) positive mothers. Haematology. 2007; 12(5): 377–80.

Tsui N.B., Hyland C.A., Gardener G.J., Danon D., Fisk N.M., Millard G. et al. Noninvasive fetal RHD genotyping by microfluidics digital PCR using maternal plasma from two alloimmunized women with the variant RHD(IVS3+1G>A) allele. Prenat. Diagn. 2013; 33(12): 1214–6.

Ustyantseva N.Yu. Immune conflicts during pregnancy. Russian J. Perinatal Med. 2022; 21(1): 15–22.

Visser G.H.A. et al. Global approach to perinatal care. Lancet Glob Health. 2019; 7(3): e305–e306.

Zwiers C. et al. Hemolytic disease of the fetus and newborn. Am. J. Obstet. Gynecol. 2017; 216(6): 563–571.